Amin Alousi

1.8k total citations
16 papers, 886 citations indexed

About

Amin Alousi is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Amin Alousi has authored 16 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 6 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Amin Alousi's work include Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Amin Alousi is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Amin Alousi collaborates with scholars based in United States, United Kingdom and Australia. Amin Alousi's co-authors include Chitra Hosing, Issa F. Khouri, Marcos de Lima, Paolo Anderlini, Rima M. Saliba, Daniel R. Couriel, Sergio Giralt, Elizabeth J. Shpall, Gabriela Rondón and Richard E. Champlin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Amin Alousi

14 papers receiving 872 citations

Peers

Countries citing papers authored by Amin Alousi

Since Specialization

Citations

This map shows the geographic impact of Amin Alousi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amin Alousi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amin Alousi more than expected).

Fields of papers citing papers by Amin Alousi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amin Alousi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amin Alousi. The network helps show where Amin Alousi may publish in the future.

Co-authorship network of co-authors of Amin Alousi

This figure shows the co-authorship network connecting the top 25 collaborators of Amin Alousi. A scholar is included among the top collaborators of Amin Alousi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amin Alousi. Amin Alousi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	A Phase 2 study of CPX‐351 in combination with venetoclax in patients with newly diagnosed high‐risk acute myeloid leukemia 2025 ·HemaSphere ·(unknown), (unknown), (unknown), Courtney D. DiNardo, Kelly S. Chien, Danielle Hammond, Wei Qiao, Yesid Alvarado, Lucia Masárová, Andres Quesada, Sherry Pierce, Álex Bataller, Guillermo Garcia‐Manero, Amin Alousi, Nicholas J. Short, (unknown), Farhad Ravandi, Hagop Kantarjian, Tapan M. Kadia	0
2	Maintenance therapy with oral decitabine plus cedazuridine after allogeneic stem cell transplantation for myelodysplastic syndrome 2025 ·Haematologica ·(unknown), Terri Lynn Shigle, (unknown), Chitra Hosing, Amin Alousi, Qaiser Bashir, Yosra Aljawai, Jeremy Ramdial, Uday Popat, Richard Champlin, Elizabeth J. Shpall, Betül Oran	0
3	Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High‐Risk Subtype That Warrants an Independent Prognostic Designation 2024 ·American Journal of Hematology ·Jayastu Senapati, Hagop M. Kantarjian, Fadi Haddad, Nicholas J. Short, Gautam Borthakur, Rashmi Kanagal‐Shamanna, Guilin Tang, Elias Jabbour, Courtney D. DiNardo, Naval Daver, Guillermo Montalban‐Bravo, (unknown), Amin Alousi, (unknown), Uday Popat, Guillermo Garcia‐Manero, Farhad Ravandi, Tapan M. Kadia	3
4	Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) 2023 ·Haematologica ·Guillaume Richard‐Carpentier, Caitlin R. Rausch, Koji Sasaki, Danielle Hammond, (unknown), Koichi Takahashi, Guilin Tang, Rashmi Kanagal‐Shamanna, Kapil N. Bhalla, Courtney D. DiNardo, Gautam Borthakur, Naveen Pemmaraju, Elizabeth J. Shpall, Amin Alousi, Naval Daver, Guillermo Garcia‐Manero, Marina Konopleva, Farhad Ravandi, Hagop M. Kantarjian, Tapan M. Kadia	11
5	Abstract CT003: Innate cell engager (ICE®) AFM13 combined with preactivated and expanded cord blood (CB)-derived NK cells for patients with refractory/relapsed CD30+ lymphoma 2022 ·Cancer Research ·Yago Nieto, Pinaki P. Banerjee, Indreshpal Kaur, Roland Bassett, Lucila Nassif Kerbauy, Rafet Başar, Mecit Kaplan, (unknown), (unknown), Christina Ganesh, Melissa Barnett, Amin Alousi, Chitra Hosing, Jeremy Ramdial, Neeraj Saini, Samer A. Srour, Karenza Alexis, A. Harstrick, Elizabeth J. Shpall, Katayoun Rezvani	13
6	A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality 2015 ·Biology of Blood and Marrow Transplantation ·Margaret L. MacMillan, Marie Robin, Andrew C. Harris, Todd E. DeFor, Paul J. Martin, Amin Alousi, Vincent T. Ho, Javier Bolaños‐Meade, James L.M. Ferrara, Richard J. Jones, Mukta Arora, Bruce R. Blazar, Shernan G. Holtan, David A. Jacobsohn, Marcelo C. Pasquini, Gèrard Socié, Joseph H. Antin, John E. Levine, Daniel J. Weisdorf	161
7	Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: results of a randomized phase II trial 2015 ·Leukemia & lymphoma ·Meghan Karuturi, Anas Younes, Luis Fayad, Larry W. Kwak, Barbara Pro, Jatin J. Shah, Yasuhiro Oki, (unknown), (unknown), (unknown), Lei Feng, Sandra Horowitz, Yago Nieto, Paolo Anderlini, Amin Alousi, Uday Popat, L. Jeffrey Medeiros, Roberto N. Miranda, Michelle A. Fanale	7
8	The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation 2014 ·Clinical Lymphoma Myeloma & Leukemia ·Yi Zhou, Rebecca Slack, Jeffrey L. Jorgensen, Sa A. Wang, Gabriela Rondón, Marcos de Lima, Elizabeth J. Shpall, Uday Popat, Stefan O. Ciurea, Amin Alousi, Muzaffar H. Qazilbash, Chitra Hosing, Susan O’Brien, Deborah A. Thomas, Hagop M. Kantarjian, L. Jeffrey Medeiros, Richard E. Champlin, Partow Kebriaei	46
9	Just‐in‐time rescue plerixafor in combination with chemotherapy and granulocyte‐colony stimulating factor for peripheral blood progenitor cell mobilization 2013 ·American Journal of Hematology ·Veronica Smith, Uday Popat, Stefan O. Ciurea, Yago Nieto, Paolo Anderlini, Gabriela Rondón, Amin Alousi, Muzaffar H. Qazilbash, Partow Kebriaei, Issa F. Khouri, Marcos de Lima, Richard Champlin, Chitra Hosing	22
10	Reversible Ureteral Obstruction due to Polyomavirus Infection after Percutaneous Nephrostomy Catheter Placement 2011 ·Biology of Blood and Marrow Transplantation ·Hassan Khan, (unknown), Armeen Mahvash, Manish Sharma, Gabriela Rondón, Amin Alousi, Elizabeth J. Shpall, Dimitrios P. Kontoyiannis, Richard E. Champlin, Stefan O. Ciurea	13
11	Steroid-Refractory Acute GVHD: Predictors and Outcomes 2011 ·Advances in Hematology ·Jason R. Westin, Rima M. Saliba, Marcos de Lima, Amin Alousi, Chitra Hosing, Muzaffar H. Qazilbash, Issa F. Khouri, Elizabeth J. Shpall, Paolo Anderlini, Gabriela Rondón, Börje S. Andersson, Richard Champlin, Daniel R. Couriel	133
12	Prophylaxis of Graft-Versus-Host Disease in Unrelated Donor Transplantation With Pentostatin, Tacrolimus, and Mini-Methotrexate: A Phase I/II Controlled, Adaptively Randomized Study 2010 ·Journal of Clinical Oncology ·Simrit Parmar, Börje S. Andersson, Daniel R. Couriel, Mark F. Munsell, Marcelo Fernández-Viña, Roy B. Jones, Elizabeth J. Shpall, Uday Popat, Paolo Anderlini, Sergio Giralt, Amin Alousi, Pedro Cano, Doyle Bosque, Chitra Hosing, Leandro de Pádua Silva, Michael Westmoreland, J. Kyle Wathen, Donald A. Berry, Richard E. Champlin, Marcos J. de Lima	17
13	A Phase III Study of Infliximab and Corticosteroids for the Initial Treatment of Acute Graft-versus-Host Disease 2009 ·Biology of Blood and Marrow Transplantation ·Daniel R. Couriel, Rima M. Saliba, Marcos de Lima, Sergio Giralt, B Andersson, Issa F. Khouri, Chitra Hosing, Cindy Ippoliti, Elizabeth J. Shpall, Richard Champlin, Amin Alousi	84
14	Mycophenolate Pharmacokinetics and Association with Response to Acute Graft-versus-Host Disease Treatment from the Blood and Marrow Transplant Clinical Trials Network 2009 ·Biology of Blood and Marrow Transplantation ·Pamala A. Jacobson, (unknown), Juan Wu, Miae Kim, Brent R. Logan, Amin Alousi, Michael Grimley, Javier Bolaños‐Meade, Vincent T. Ho, John E. Levine, Daniel J. Weisdorf	27
15	Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma 2009 ·Blood ·Constantine S. Tam, Roland L. Bassett, Celina Ledesma, Martin Körbling, Amin Alousi, Chitra Hosing, (unknown), Robyn K. Harrell, Gabriela Rondón, Sergio Giralt, Paolo Anderlini, Uday Popat, Barbara Pro, Barry I. Samuels, Frederick Hagemeister, L. Jeffrey Medeiros, Richard E. Champlin, Issa F. Khouri	134
16	Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab 2008 ·Blood ·Issa F. Khouri, Peter McLaughlin, Rima M. Saliba, Chitra Hosing, Martin Körbling, Ming S. Lee, L. Jeffrey Medeiros, Luis Fayad, Felipe Samaniego, Amin Alousi, Paolo Anderlini, Daniel R. Couriel, Marcos de Lima, Sergio Giralt, Sattva S. Neelapu, Naoto T. Ueno, Barry I. Samuels, Fredrick Hagemeister, Larry W. Kwak, Richard E. Champlin	215

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact